- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04635579
Personalized Blood Flow Restriction for Anterior Cruciate Ligament Rehabilitation
February 3, 2022 updated by: Scott Telfer, EngD, University of Washington
This is a cross-sectional study on the use of personalized blood flow restriction during rehabilitation exercises and its effects on biomechanics on people who have had an anterior cruciate ligament reconstruction and healthy controls
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Rehabilitation after surgical reconstruction of the anterior cruciate ligament (ACL) aims to reestablish the function of the knee.
However, regaining previous levels of strength is challenging, with long-term muscle weakness frequently reported and thought to play a key role in the increased risk of knee osteoarthritis for individuals with a history of ACL damage.
Effectively building muscle strength requires exercises with high resistance loads, however the joint stress and risk of further injury makes these types of activities inappropriate and unsafe for those rehabilitating after ACL reconstruction surgery and other injuries.
Personalized blood flow restriction (BFR) training is a technique where the blood flow to the muscles being exercised is controlled by a pressure cuff to a predefined level, and has been shown to increase strength while exercising with significantly lower loads.
Early results have been promising, however the effects of BFR on the biomechanics of the exercise as well as the acceptability in the ACL reconstruction population have not been explored.
In this application, we propose a cross-sectional study designed to test the acceptability of BFR training for those undergoing rehabilitation from ACL reconstruction surgery and healthy controls during free standing exercises.
We will also investigate the biomechanical effects of this rehabilitation technique.
This application is part of a larger program of musculoskeletal research in this area being developed by the team.
The results from the proposed project will inform the design of a clinical trial of personalized BFR after ACL reconstruction.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria (ACL-R group):
- Must be undergoing rehabilitation for anterior cruciate ligament reconstruction surgery
- Must be at least 3 months post surgery.
- Attending clinician should confirm that they are able to take part in the trial
Exclusion Criteria:
- Any other orthopaedic, neurological, or other condition within the last 12 months that would affect ability to carry out the required exercises
- Any medical conditions that may affect circulation including, but not limited to, deep vein thrombosis, high blood pressure, and cardiac disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Anterior cruciate ligament reconstruction group
Single session blood flow restriction of lower limb to individuals who have undergone anterior ligament reconstruction surgery
|
Intervention restricts blood flow to the lower limb as a percentage of the limb occlusion pressure
|
|
Active Comparator: Control group
Single session blood flow restriction of lower limb to individuals who have no musculoskeletal injuries
|
Intervention restricts blood flow to the lower limb as a percentage of the limb occlusion pressure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee Flexion
Time Frame: 6 minutes
|
Maximum difference in flexion motion of knee while performing exercise between baseline and blood flow restriction condition.
Measured in degrees
|
6 minutes
|
|
Knee Internal Rotation
Time Frame: 6 minutes
|
Maximum difference in internal rotation of knee while performing exercise between baseline and blood flow restriction condition.
Measured in degrees
|
6 minutes
|
|
Knee Varus
Time Frame: 6 minutes
|
Maximum difference in varus motion of knee while performing exercise between baseline and blood flow restriction condition.
Measured in degrees
|
6 minutes
|
|
Hip Flexion
Time Frame: 6 minutes
|
Maximum difference in flexion motion of hip while performing exercise between baseline and blood flow restriction condition.
Measured in degrees
|
6 minutes
|
|
Hip Adduction
Time Frame: 6 minutes
|
Maximum difference in adduction motion of hip while performing exercise between baseline and blood flow restriction condition.
Measured in degrees
|
6 minutes
|
|
Hip Internal Rotation
Time Frame: 6 minutes
|
Maximum difference in internal rotation motion of hip while performing exercise between baseline and blood flow restriction condition.
Measured in degrees
|
6 minutes
|
|
Knee Extension Moment
Time Frame: 6 minutes
|
Maximum difference in extension moment of knee while performing exercise between baseline and blood flow restriction condition.
Measured in Newton meters per kilogram
|
6 minutes
|
|
Knee Internal Rotation Moment
Time Frame: 6 minutes
|
Maximum difference in internal rotation moment of knee while performing exercise between baseline and blood flow restriction condition.
Measured in Newton meters per kilogram
|
6 minutes
|
|
Knee Adduction Moment
Time Frame: 6 minutes
|
Maximum difference in adduction moment of knee while performing exercise between baseline and blood flow restriction condition.
Measured in Newton meters per kilogram
|
6 minutes
|
|
Hip Extension Moment
Time Frame: 6 minutes
|
Maximum difference in extension moment of hip while performing exercise between baseline and blood flow restriction condition.
Measured in Newton meters per kilogram.
|
6 minutes
|
|
Hip Adduction Moment
Time Frame: 6 minutes
|
Maximum difference in adduction moment of hip while performing exercise between baseline and blood flow restriction condition.
Measured in Newton meters per kilogram
|
6 minutes
|
|
Hip Internal Rotation Moment
Time Frame: 6 minutes
|
Maximum difference in internal rotation moment of hip while performing exercise between baseline and blood flow restriction condition.
Measured in Newton meters per kilogram
|
6 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise Difficulty Score
Time Frame: 6 minutes
|
Numerical Analogue Scale, 0-10, higher scores indicate greater difficulty
|
6 minutes
|
|
Exercise Discomfort Score
Time Frame: 6 minutes
|
Numerical Analogue Scale, 0-10, higher scores indicate greater discomfort
|
6 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Scott Telfer, EngD, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 8, 2018
Primary Completion (Actual)
November 2, 2020
Study Completion (Actual)
November 2, 2020
Study Registration Dates
First Submitted
November 2, 2020
First Submitted That Met QC Criteria
November 13, 2020
First Posted (Actual)
November 19, 2020
Study Record Updates
Last Update Posted (Actual)
February 28, 2022
Last Update Submitted That Met QC Criteria
February 3, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00004543
- 5P30AR072572-02 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Data will be made available to researchers on request.
Dataset includes all kinematic, kinetic and patient reported data.
IPD Sharing Time Frame
11/19/2021 - 11/18/2026
IPD Sharing Supporting Information Type
- Study Protocol
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anterior Cruciate Ligament Tear
-
Taipei Hospital, Ministry of Health and WelfareRecruitingAnterior Cruciate Ligament Tear | Posterior Cruciate Ligament TearTaiwan
-
University of LahoreCompletedLow Level Laser Therapy Versus Short Wave Diathermy in Patients With Anterior Cruciate Ligament TearAnterior Cruciate Ligament (ACL) TearPakistan
-
Ankara City Hospital BilkentRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearTurkey
-
Sanford HealthActive, not recruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited States
-
University of Colorado, DenverChildren's Hospital ColoradoActive, not recruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited States
-
Miach OrthopaedicsActive, not recruitingAnterior Cruciate Ligament Tear | Anterior Cruciate Ligament InjuryUnited States
-
Isabella JaramilloMcMaster UniversityRecruitingAnterior Cruciate Ligament | Anterior Cruciate Ligament (ACL) TearCanada
-
Karolinska InstitutetRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearSweden
-
Bahçeşehir UniversityIstanbul University - Cerrahpasa (IUC)CompletedAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearTurkey
-
University GhentResearch Foundation FlandersRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Anterior Cruciate Ligament Reconstruction | ACL | ACL Injury | ACL Tear | Arthrogenic Muscle Inhibition | Arthrogenic Muscle ResponsesBelgium
Clinical Trials on Blood flow restriction
-
China Medical University HospitalCompletedBlood Flow Restriction | draw-in Maneuver | Transverse AbdominisTaiwan
-
George Fox UniversityUnknownMuscle Weakness | Can Blood Flow Restriction Therapy Augments Strength Gains in the Rotator CuffUnited States
-
Rush University Medical CenterWithdrawnAnterior Cruciate Ligament Injuries | Physical Therapy | ACL
-
University of West AtticaNot yet recruiting
-
Caitlin ConleyThe Cleveland ClinicRecruitingWounds and Injuries | Knee Injuries | Patellar Dislocation | Leg InjuryUnited States
-
University of MinnesotaFairview Health ServicesCompleted
-
Ibadat International University, IslamabadNot yet recruiting
-
University of Colorado, DenverRecruitingACL TearUnited States
-
University of AarhusAarhus University Hospital; Aalborg University Hospital; Gødstrup Hospital; Regionshospitalet...RecruitingAchilles Tendon RuptureDenmark
-
Womack Army Medical CenterThe Geneva Foundation; Telemedicine & Advanced Technology Research CenterTerminatedAchilles TendinopathyUnited States